Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

IF 9.5 2区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Experimental and Molecular Medicine Pub Date : 2024-10-28 DOI:10.1038/s12276-024-01343-7

Jung-Hwan Baek, Myung Sup Kim, Hye Ryeon Jung, Min-Seon Hwang, Chan-ho Lee, Dai Hoon Han, Yong-ho Lee, Eugene C. Yi, Seung-Soon Im, Ilseon Hwang, Kyungeun Kim, Joon-Yong Chung, Kyung-Hee Chun

引用次数: 0

查看原文本刊更多论文

作者更正：消融去泛素酶 USP15 可改善非酒精性脂肪肝和非酒精性脂肪性肝炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Experimental and Molecular Medicine 医学-生化与分子生物学

CiteScore

19.50

自引率

0.80%

发文量

166

审稿时长

3 months

期刊介绍： Experimental & Molecular Medicine (EMM) stands as Korea's pioneering biochemistry journal, established in 1964 and rejuvenated in 1996 as an Open Access, fully peer-reviewed international journal. Dedicated to advancing translational research and showcasing recent breakthroughs in the biomedical realm, EMM invites submissions encompassing genetic, molecular, and cellular studies of human physiology and diseases. Emphasizing the correlation between experimental and translational research and enhanced clinical benefits, the journal actively encourages contributions employing specific molecular tools. Welcoming studies that bridge basic discoveries with clinical relevance, alongside articles demonstrating clear in vivo significance and novelty, Experimental & Molecular Medicine proudly serves as an open-access, online-only repository of cutting-edge medical research.